Protection Against Rabbit Hemorrhagic Disease Virus Strains: Efficacy of a New Commercial Recombinant RHDV2 Capsid Protein VP60 Vaccine. [PDF]
Fontseca M +6 more
europepmc +1 more source
Temporal Dynamics and Turnover of Rabbit Hemorrhagic Disease Virus 2 (RHDV2/GI.2) in Wild Lagomorphs from Northeastern Spain. [PDF]
Estruch J +8 more
europepmc +1 more source
Molecular characterization of rabbit hemorrhagic disease virus type 2 and long-lasting protection conferred by a VLP-based vaccine. [PDF]
Wang Y +16 more
europepmc +1 more source
Variation of rabbit serum IgA in relation to RHDV vaccination and infection: implications for serological diagnosis and epidemiological investigations. [PDF]
Capucci L +5 more
europepmc +1 more source
Development of a Rapid and Sensitive AlphaLISA-Based Assay for Lassa Virus Glycoprotein Detection. [PDF]
Cai H +11 more
europepmc +1 more source
Crimean-Congo Hemorrhagic Fever Virus Circulation in Wild European Rabbits, Portugal, 2018-2023. [PDF]
Baptista C, Santos N, Vial L, Jori F.
europepmc +1 more source
Simultaneous Occurrence of Field Epidemics of Rabbit Hemorrhagic Disease (RHD) in Poland Due to the Co-Presence of <i>Lagovirus europaeus</i> GI.1 (RHDV)/GI.1a (RHDVa) and GI.2 (RHDV2) Genotypes. [PDF]
Fitzner A +2 more
europepmc +1 more source
Griffithsin-mediated inhibition of cellular entry of hemorrhagic fever viruses and insights into its mechanisms. [PDF]
Saito T +20 more
europepmc +1 more source

